Clinical report
A novel homozygous KY variant causing a complex neurological disorder

https://doi.org/10.1016/j.ejmg.2020.104031Get rights and content

Highlights

  • Patients with a homozygous KY frameshift variant are presented.

  • We report mixed upper and lower motor neuron features in the same individual.

  • Additional features include toe walking, pes equinovarus, and a speech disorder.

  • KY-associated disorders manifest in a broad phenotype spectrum.

Abstract

Mutations in the gene kyphoscoliosis peptidase (KY) are known to cause myofibrillar myopathy-7 and hereditary spastic paraplegia. We investigated the genetic cause of a complex neurological phenotype in a consanguineous Pakistani family with four affected members, manifesting lower limb spasticity and weakness, toe walking, pes equinovarus, and a speech disorder. Genome-wide linkage analysis with microsatellite markers delineated chromosome 3q22.2-q24 harboring the disease gene. Whole exome sequencing was performed for two subjects, identifying a homozygous 14-bp frameshift deletion NM_178554.6:c.842_855del; p(Val281GlyfsTer18) in KY. The variant segregated with the phenotype and was absent from public databases and 100 ethnically matched controls. We confirm a novel homozygous KY variant causing a complex neurological phenotype in this family. A review of previously reported KY variants suggests that variants in this gene can cause a spectrum of neurological phenotypes.

Introduction

Homozygous loss of function variants in the gene kyphoscoliosis peptidase (KY) have primarily been implicated as a cause of rare neuromuscular phenotypes such as myofibrillar myopathy (MFM). The MFMs are a heterogeneous group of hereditary muscle diseases characterized by ectopic protein aggregates and a distinct pattern of myofibrillar disorganization (Fichna et al., 2018). Two reported variants, NM_178554.6:c.405C > A; p.(Tyr135Ter) and NM_178554.6:c.1071delG; p.(Thr358LeufsTer3) cause MFM7, characterized by pes cavus, muscular weakness and reduced reflexes in two Arab-Israeli brothers (Straussberg et al., 2016), and a Turkish girl (Hedberg-Oldfors et al., 2016), respectively. Another study reported a frameshift variant, NM_178554.6:c.51_52insTATCGACATGTGCTGTATCTATCGACAT; p.(Val18TyrfsTer56) causing hereditary spastic paraplegia (HSP) in twelve Arab-Bedouin individuals (Yogev et al., 2017). More recently, an Iranian patient with lower limb deformity and motor disorders was found to have a nonsense NM_178554.6:c.415C > T; p.(Arg139Ter) variant in KY (Ebrahimzadeh-Vesal et al., 2018).

The autosomal recessive ky mouse mutant exhibits a neuromuscular and skeletal phenotype with primary degenerative myopathy preceding chronic thoraco-lumbar kyphoscoliosis (Blanco et al., 2001). KY expression has been detected in several tissues including the brain (Fagerberg et al., 2014), and it encodes a protease which interacts with several muscle proteins such as filamin C (FLNC) and myosin-binding protein C (MYBPC1), suggesting that KY is an central part of the protein networks underlying the molecular mechanism of many limb-girdle muscular dystrophies (Beatham et al., 2004).

Section snippets

Clinical report

We performed genome-wide linkage analysis and whole exome sequencing to find the underlying cause of a complex neurological disorder in four of six affected individuals of a family (Fig. 1A, 2 family members were deceased and not available to study). This consanguineous family with multiple affected family members was selected for a potential gene discovery or novel gene-phenotype association. The study was conducted after approval by the institutional review board of School of Biological

Discussion

Our study has expanded both the phenotypic and genotypic spectrum due to KY variants. Interestingly, all KY variants described to date are predicted to either severely truncate the encoded protein or invoke nonsense mediated decay of the mRNA (Table 1). The KY variants may manifest with a spectrum of neurological phenotypes including myopathic, neurogenic or spastic paraplegia presentations.

The phenotype in the presented family included a mixture of upper and lower motor neuron signs. Given the

CRediT authorship contribution statement

Beenish Arif: Methodology, Investigation, Data curation, Writing - original draft, Writing - review & editing. Arisha Rasheed: Investigation, Data curation, Writing - review & editing. Kishore R. Kumar: Methodology, Investigation, Writing - review & editing. Amara Fatima: Methodology, Investigation, Data curation, Writing - review & editing. Ghazanfar Abbas: Investigation, Writing - review & editing. Elizabeth Wohler: Data curation, Writing - review & editing. Nara Sobriera: Data curation,

Declaration of competing interest

The authors declare that they have no conflict of interest.

Acknowledgements

We thank the family for participating in this research. We are grateful to Dr. Akbar Malik, and Huma Tariq for their help in the study. KRK receives a philanthropic grant from the Paul Ainsworth Family Foundation and a Working Group Co-Lead Award from the Michael J. Fox Foundation, Aligning Science Across Parkinson's (ASAP) initiative. KL is supported by German Research Foundation (DFG, grant LO1553/8-1). Whole exome sequencing was performed by Baylor-Hopkins Center for Mendelian Genomics. This

References (13)

There are more references available in the full text version of this article.

Cited by (3)

  • Genotypic and phenotypic spectrum of Myofibrillar Myopathy 7 as a result of Kyphoscoliosis Peptidase deficiency: The first description of a missense mutation in KY and literature review

    2022, European Journal of Medical Genetics
    Citation Excerpt :

    The high clinical overlap of symptoms and the resemblance of HSP to other clinical entities makes the molecular diagnosis of HSP essential (Hedera, 2021; Klebe et al., 2015). Although OMIM database only associates MFM-7 with mutations in KY, a handful of the previous studies reported that HSP is also caused by mutations in KY (Arif et al., 2020; Yogev et al., 2017). The main features of HSP are weakness and spasticity in both lower limbs.

View full text